First Mercantile Trust’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $233K | Sell |
4,159
-285
| -6% | -$16K | 0.03% | 363 |
|
|
2021
Q2 | $270K | Sell |
4,444
-246
| -5% | -$14.9K | 0.03% | 320 |
|
|
2021
Q1 | $329K | Sell |
4,690
-1,835
| -28% | -$129K | 0.04% | 268 |
|
|
2020
Q4 | $390K | Sell |
6,525
-522
| -7% | -$31.2K | 0.04% | 233 |
|
|
2020
Q3 | $404K | Sell |
7,047
-273
| -4% | -$15.7K | 0.05% | 208 |
|
|
2020
Q2 | $384K | Buy |
7,320
+1,101
| +18% | +$57.8K | 0.05% | 223 |
|
|
2020
Q1 | $209K | Sell |
6,219
-994
| -14% | -$33.4K | 0.03% | 328 |
|
|
2019
Q4 | $327K | Sell |
7,213
-173
| -2% | -$7.84K | 0.04% | 317 |
|
|
2019
Q3 | $281K | Buy |
7,386
+2,923
| +65% | +$111K | 0.03% | 377 |
|
|
2019
Q2 | $194K | Buy |
4,463
+728
| +19% | +$31.6K | 0.02% | 454 |
|
|
2019
Q1 | $142K | Buy |
+3,735
| New | +$142K | 0.03% | 566 |
|
|
2016
Q2 | – | Sell |
-9,303
| Closed | -$493K | – | 910 |
|
|
2016
Q1 | $493K | Sell |
9,303
-1,000
| -10% | -$53K | 0.06% | 382 |
|
|
2015
Q4 | $791K | Buy |
+10,303
| New | +$791K | 0.08% | 307 |
|
|
2015
Q1 | – | Sell |
-4,463
| Closed | -$395K | – | 1115 |
|
|
2014
Q4 | $395K | Sell |
4,463
-10,845
| -71% | -$960K | 0.03% | 566 |
|
|
2014
Q3 | $1.48M | Sell |
15,308
-3,980
| -21% | -$386K | 0.12% | 212 |
|
|
2014
Q2 | $1.77M | Buy |
19,288
+4,538
| +31% | +$417K | 0.14% | 188 |
|
|
2014
Q1 | $1.03M | Buy |
14,750
+6,850
| +87% | +$479K | 0.08% | 358 |
|
|
2013
Q4 | $454K | Sell |
7,900
-300
| -4% | -$17.2K | 0.04% | 586 |
|
|
2013
Q3 | $394K | Buy |
+8,200
| New | +$394K | 0.03% | 613 |
|